In late November 2013, USTR reportedly introduced a revised proposal that would attempt to
balance the provision of certain patent protections with the ability of developing countries in the TPP to access needed medicines.69 The new proposal tracks the intent of the May 10th provisions
by reportedly providing options to developing countries in the TPP concerning certain patent
protections, at least as long as they remained a developing country based on some agreed-upon
benchmark. According to reports, the proposal would allow developing countries to follow the
provisions of the U.S. Peru FTA, under which